CI
Cockrell Interests
Activity from announced rounds
Activity in this selectionAug 31, 2026 · Aug 1, 2026
Cockrell Interests is the investment entity named in financing coverage for Stellular Bio and ai3Bio.
Recorded funding activity
Stellular develops platelet-derived biologic therapies for ocular-surface diseases. ai3Bio develops antibody and lipid-nanoparticle approaches intended to remove disease-causing Th17 immune cells. The company records connect the same named investor to distinct therapeutic programs.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.